CoChat

In Vitro Primary Human and Animal Cell-Based Blood−Brain Barrier Models as a Screening Tool in Drug Discovery

Lacombe, Olivier, Videau, Orianne, Chevillon, Delphine, Guyot, Anne-Cécile, Contreras, Christelle, Blondel, Sandrine, Nicolas, Laurence, Ghettas, Aurélie, Bénech, Henri, Thevenot, Etienne, Pruvost, Alain, Bolze, Sébastien, Krzaczkowski, Lucie, Prévost, Colette, Mabondzo, Aloïse · 2011 · Molecular Pharmaceutics
Cited by 66

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Brain penetration is characterized by its extent and rate and is influenced by drug physicochemical properties, plasma exposure, plasma and brain protein binding and BBB permeability. This raises questions related to physiology, interspecies differences and in vitro/in vivo extrapolation. We herein discuss the use of in vitro human and animal BBB model as a tool to improve CNS compound selection. These cell-based BBB models are characterized by low paracellular permeation, well-developed tight junctions and functional efflux transporters. A study of twenty drugs shows similar compound ranking between rat and human models although with a 2-fold higher permeability in rat. cLogP < 5, PSA < 120 Å, MW < 450 were confirmed as essential for CNS drugs. An in vitro/in vivo correlation in rat (R² = 0.67; P = 2 × 10⁻⁴) was highlighted when in vitro permeability and efflux were considered together with plasma exposure and free fraction. The cell-based BBB model is suitable to optimize CNS-drug selection, to study interspecies differences and then to support human brain exposure prediction.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/mp1004614

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 66

Metadata

Authors
Lacombe, O., Videau, O., Chevillon, D., Guyot, A.-C., Contreras, C., Blondel, S., Nicolas, L., Ghettas, A., Bénech, H., Thevenot, E., Pruvost, A., Bolze, S., Krzaczkowski, L., Prévost, C., & Mabondzo, A.
Venue
Molecular Pharmaceutics
Published
2011-04-15
Volume
8
Issue
3
Pages
651-663
ISSN
  • 1543-8384 (ISSN-L)
  • 1543-8392
OpenAlex
W2334456997
Cited by
66
References
1
FWCI
4.43
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: In Vitro Primary Human and Animal Cell-Based Blood−Brain Barrier Models as a Screening Tool in Drug Discovery. https://app.cochat.ai/papers/10.1021/mp1004614
The paper
Lacombe, O., Videau, O., Chevillon, D., Guyot, A.-C., Contreras, C., Blondel, S., Nicolas, L., Ghettas, A., Bénech, H., Thevenot, E., Pruvost, A., Bolze, S., Krzaczkowski, L., Prévost, C., & Mabondzo, A. (2011). In Vitro Primary Human and Animal Cell-Based Blood−Brain Barrier Models as a Screening Tool in Drug Discovery. Molecular Pharmaceutics. https://doi.org/10.1021/mp1004614

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.